SLTM

SOLTA MEDICAL INCCIK 1171298 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for SLTM PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for SLTM

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Ku Mingo	Vice President of Global Sales	9	$0	$0	2014-01-23
Holthe David	Director	5	$0	$0	2014-01-23
Parr Lisa D	VP,Regulatory/Clinical Affairs	4	$5.6K	$0	2014-01-23
Nardoci Jeffrey C	Vice President of Marketing	33	$0	$249.0K	2014-01-23
Graebner Linda	Director	6	$32.0K	$0	2014-01-23
Ferrari H Daniel	Vice President of Finance	28	$0	$46.7K	2014-01-23
Heigel Douglas W	VP Operations	31	$0	$53.2K	2014-01-23
GLENN JOHN	Chief Financial Officer	25	$0	$0	2014-01-23
STANG ERIC B	Director	6	$0	$0	2014-01-23
COVERT HAROLD L	Director	5	$0	$0	2014-01-23
SIECZKAREK MARK M	Interim Chairman/President/CEO	11	$261.0K	$0	2014-01-23
McCarthy Cathy L	Director	7	$21.3K	$0	2014-01-23
Yorkey Thomas J.	Vice President, Research & Dev	16	$0	$0	2013-02-10
FANNING STEPHEN J	President & CEO	16	$0	$0	2013-02-10
Knowlton Edward W	Director	5	$0	$0	2013-01-16
Foss Kristine A	VP,Regulatory,Clinical,Quality	6	$0	$0	2012-02-10
Brodie William	Vice President of Global Sales	6	$0	$0	2012-02-10

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
SIECZKAREK MARK M	Interim Chairman/President/C	D To issuer deriv	2014-01-23	2014-01-27	25,000	$1.53	$38.3K	0	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	D To issuer deriv	2014-01-23	2014-01-27	25,000	$0.45	$11.3K	0	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise deriv	2014-01-23	2014-01-27	28,620	—	$0	0	SEC↗
GLENN JOHN	Chief Financial Officer	D To issuer deriv	2014-01-23	2014-01-27	139,000	$1.92	$266.9K	0	SEC↗
GLENN JOHN	Chief Financial Officer	D To issuer deriv	2014-01-23	2014-01-27	175,000	$1.01	$176.8K	0	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise deriv	2014-01-23	2014-01-27	12,936	—	$0	0	SEC↗
Ferrari H Daniel	Vice President of Finance	D To issuer deriv	2014-01-23	2014-01-27	100,000	$1.01	$101.0K	0	SEC↗
Ferrari H Daniel	Vice President of Finance	D To issuer deriv	2014-01-23	2014-01-27	8,000	$1.02	$8.2K	0	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise deriv	2014-01-23	2014-01-27	14,906	—	$0	0	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise deriv	2014-01-23	2014-01-27	7,789	—	$0	0	SEC↗
Ferrari H Daniel	Vice President of Finance	D To issuer deriv	2014-01-23	2014-01-27	56,000	$1.92	$107.5K	0	SEC↗
Heigel Douglas W	VP Operations	D To issuer deriv	2014-01-23	2014-01-27	74,000	$1.92	$142.1K	0	SEC↗
Heigel Douglas W	VP Operations	D To issuer deriv	2014-01-23	2014-01-27	20,000	$1.02	$20.4K	0	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2014-01-23	2014-01-27	7,546	—	$0	0	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2014-01-23	2014-01-27	17,292	—	$0	0	SEC↗
Heigel Douglas W	VP Operations	D To issuer deriv	2014-01-23	2014-01-27	99,000	$1.01	$100.0K	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	M Exercise deriv	2014-01-23	2014-01-27	14,906	—	$0	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	M Exercise deriv	2014-01-23	2014-01-27	8,346	—	$0	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	D To issuer deriv	2014-01-23	2014-01-27	68,750	$0.44	$30.3K	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	D To issuer deriv	2014-01-23	2014-01-27	52,085	$1.01	$52.6K	0	SEC↗
Parr Lisa D	VP Regulatory/Clinical Affai	D To issuer deriv	2014-01-23	2014-01-27	100,000	$0.15	$15.0K	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer deriv	2014-01-23	2014-01-27	3,000	$0.17	$510	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer deriv	2014-01-23	2014-01-27	50,000	$0.15	$7.5K	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer deriv	2014-01-23	2014-01-27	2,500	$0.36	$900	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer deriv	2014-01-23	2014-01-27	2,000	$1.41	$2.8K	0	SEC↗
Ku Mingo	Vice President of Global Sal	M Exercise deriv	2014-01-23	2014-01-27	5,963	—	$0	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer deriv	2014-01-23	2014-01-27	20,000	$1.55	$31.0K	0	SEC↗
COVERT HAROLD L	Director	D To issuer deriv	2014-01-23	2014-01-27	25,000	$1.53	$38.3K	0	SEC↗
COVERT HAROLD L	Director	D To issuer deriv	2014-01-23	2014-01-27	25,000	$0.45	$11.3K	0	SEC↗
McCarthy Cathy L	Director	D To issuer deriv	2014-01-23	2014-01-27	25,000	$0.45	$11.3K	0	SEC↗
STANG ERIC B	Director	D To issuer deriv	2014-01-23	2014-01-27	25,000	$0.45	$11.3K	0	SEC↗
STANG ERIC B	Director	D To issuer deriv	2014-01-23	2014-01-27	50,000	$1.43	$71.5K	0	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	U Tender	2014-01-23	2014-01-27	269,514	$2.92	$787.0K	0	SEC↗
GLENN JOHN	Chief Financial Officer	U Tender	2014-01-23	2014-01-27	28,620	$2.92	$83.6K	0	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise	2014-01-23	2014-01-27	28,620	—	$0	28,620	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise	2014-01-23	2014-01-27	12,936	—	$0	12,936	SEC↗
GLENN JOHN	Chief Financial Officer	U Tender	2014-01-23	2014-01-27	337,963	$2.92	$986.9K	0	SEC↗
GLENN JOHN	Chief Financial Officer	U Tender	2014-01-23	2014-01-27	12,936	$2.92	$37.8K	0	SEC↗
Ferrari H Daniel	Vice President of Finance	U Tender	2014-01-23	2014-01-27	14,906	$2.92	$43.5K	0	SEC↗
Ferrari H Daniel	Vice President of Finance	U Tender	2014-01-23	2014-01-27	7,789	$2.92	$22.7K	0	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise	2014-01-23	2014-01-27	14,906	—	$0	14,906	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise	2014-01-23	2014-01-27	7,789	—	$0	7,789	SEC↗
Ferrari H Daniel	Vice President of Finance	U Tender	2014-01-23	2014-01-27	194,643	$2.92	$568.4K	0	SEC↗
Heigel Douglas W	VP Operations	D To issuer	2014-01-23	2014-01-27	299,744	$2.92	$875.3K	0	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2014-01-23	2014-01-27	7,546	—	$0	7,546	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2014-01-23	2014-01-27	17,292	—	$0	17,292	SEC↗
Heigel Douglas W	VP Operations	D To issuer	2014-01-23	2014-01-27	7,546	$2.92	$22.0K	0	SEC↗
Heigel Douglas W	VP Operations	D To issuer	2014-01-23	2014-01-27	17,292	$2.92	$50.5K	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	U Tender	2014-01-23	2014-01-27	130,580	$2.92	$381.3K	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	M Exercise	2014-01-23	2014-01-27	8,346	—	$0	8,346	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	M Exercise	2014-01-23	2014-01-27	14,906	—	$0	14,906	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	U Tender	2014-01-23	2014-01-27	8,346	$2.92	$24.4K	0	SEC↗
Nardoci Jeffrey C	VP Worldwide Mktg/GM Surg Su	U Tender	2014-01-23	2014-01-27	14,906	$2.92	$43.5K	0	SEC↗
Parr Lisa D	VP Regulatory/Clinical Affai	D To issuer	2014-01-23	2014-01-27	3,524	$2.92	$10.3K	0	SEC↗
Ku Mingo	Vice President of Global Sal	M Exercise	2014-01-23	2014-01-27	5,963	—	$0	5,963	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer	2014-01-23	2014-01-27	41,378	$2.92	$120.8K	0	SEC↗
Ku Mingo	Vice President of Global Sal	D To issuer	2014-01-23	2014-01-27	5,963	$2.92	$17.4K	0	SEC↗
COVERT HAROLD L	Director	U Tender	2014-01-23	2014-01-27	74,602	$2.92	$217.8K	0	SEC↗
Graebner Linda	Director	U Tender	2014-01-23	2014-01-27	69,536	$2.92	$203.0K	0	SEC↗
Holthe David	Director	U Tender	2014-01-23	2014-01-27	5,435,993	$2.92	$15.87M	0	SEC↗
Holthe David	Director	U Tender	2014-01-23	2014-01-27	96,501	$2.92	$281.8K	0	SEC↗
McCarthy Cathy L	Director	U Tender	2014-01-23	2014-01-27	109,602	$2.92	$320.0K	0	SEC↗
STANG ERIC B	Director	U Tender	2014-01-23	2014-01-27	31,627	$2.92	$92.4K	0	SEC↗
STANG ERIC B	Director	U Tender	2014-01-23	2014-01-27	48,097	$2.92	$140.4K	0	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	A Award	2013-12-31	2014-01-02	7,710	—	$0	268,598	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	A Award	2013-11-30	2013-12-03	10,095	—	$0	260,888	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2013-11-20	2013-11-22	46,875	—	$0	0	SEC↗
Heigel Douglas W	VP Operations	S Sale	2013-11-20	2013-11-22	27,583	$1.93	$53.2K	299,744	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2013-11-20	2013-11-22	46,875	$1.10	$51.6K	327,327	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	A Award	2013-10-31	2013-11-04	9,461	—	$0	250,793	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	A Award	2013-09-30	2013-11-04	9,151	—	$0	241,332	SEC↗
SIECZKAREK MARK M	Interim Chairman/President/C	A Award	2013-08-30	2013-11-04	7,579	—	$0	232,181	SEC↗
Parr Lisa D	VP,Regulatory/Clinical Affai	P Buy	2013-08-19	2013-08-21	2,733	$2.05	$5.6K	2,733	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2013-07-22	2013-07-24	17,167	—	$0	0	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2013-07-22	2013-07-24	17,167	$0.70	$12.0K	280,452	SEC↗
STANG ERIC B	Director	A Award	2013-06-05	2013-06-07	31,627	—	$0	31,627	SEC↗
SIECZKAREK MARK M	Director	A Award	2013-06-05	2013-06-07	31,627	—	$0	224,602	SEC↗
COVERT HAROLD L	Director	A Award	2013-06-05	2013-06-07	31,627	—	$0	74,602	SEC↗
McCarthy Cathy L	Director	A Award	2013-06-05	2013-06-07	31,627	—	$0	109,602	SEC↗
Graebner Linda	Director	A Award	2013-06-05	2013-06-07	31,627	—	$0	69,536	SEC↗
Graebner Linda	Director	P Buy	2013-05-30	2013-06-03	5,000	$2.20	$11.0K	32,909	SEC↗
Graebner Linda	Director	P Buy	2013-05-30	2013-06-03	5,000	$2.23	$11.2K	37,909	SEC↗
McCarthy Cathy L	Director	P Buy	2013-05-17	2013-05-21	10,000	$2.13	$21.3K	77,975	SEC↗
Graebner Linda	Director	P Buy	2013-05-10	2013-06-03	5,000	$1.97	$9.8K	27,909	SEC↗
SIECZKAREK MARK M	Director	P Buy	2013-05-06	2013-05-07	150,000	$1.74	$261.0K	192,975	SEC↗
Holthe David	Director	A Award	2013-02-26	2013-02-28	34,782	—	$0	96,501	SEC↗
Holthe David	Director	A Award	2013-02-26	2013-02-28	5,435,993	—	$0	5,435,993	SEC↗
Holthe David	Director	A Award	2013-02-26	2013-02-28	61,719	—	$0	61,719	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	S Sale	2013-02-22	2013-02-26	50,000	$2.30	$115.0K	109,596	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2013-02-10	2013-02-12	6,285	$2.56	$16.1K	159,596	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2013-02-10	2013-02-12	10,418	$2.56	$26.7K	331,164	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2013-02-10	2013-02-12	7,312	$2.56	$18.7K	263,285	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2013-02-10	2013-02-12	6,664	$2.56	$17.1K	189,543	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2013-02-10	2013-02-12	8,667	$2.56	$22.2K	154,224	SEC↗
FANNING STEPHEN J	Chairman President & CEO	F Tax w/h	2013-02-10	2013-02-12	26,655	$2.56	$68.2K	779,212	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise deriv	2013-02-09	2013-02-12	22,958	—	$0	84,338	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2013-02-09	2013-02-12	26,710	—	$0	89,376	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise deriv	2013-02-09	2013-02-12	24,343	—	$0	82,697	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise deriv	2013-02-09	2013-02-12	11,613	—	$0	87,195	SEC↗
FANNING STEPHEN J	Chairman President & CEO	M Exercise deriv	2013-02-09	2013-02-12	97,373	—	$0	345,090	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise	2013-02-09	2013-02-12	22,958	—	$0	174,302	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2013-02-09	2013-02-12	8,421	$2.56	$21.6K	165,881	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2013-02-09	2013-02-12	13,959	$2.56	$35.7K	341,582	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise	2013-02-09	2013-02-12	38,056	—	$0	355,541	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2013-02-09	2013-02-12	9,798	$2.56	$25.1K	270,597	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2013-02-09	2013-02-12	26,710	—	$0	280,395	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise	2013-02-09	2013-02-12	24,343	—	$0	205,137	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2013-02-09	2013-02-12	8,930	$2.56	$22.9K	196,207	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise	2013-02-09	2013-02-12	11,613	—	$0	167,151	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2013-02-09	2013-02-12	4,260	$2.56	$10.9K	162,891	SEC↗
FANNING STEPHEN J	Chairman President & CEO	F Tax w/h	2013-02-09	2013-02-12	35,717	$2.56	$91.4K	805,867	SEC↗
FANNING STEPHEN J	Chairman President & CEO	M Exercise	2013-02-09	2013-02-12	97,373	—	$0	841,584	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise deriv	2013-02-08	2013-02-12	26,800	—	$0	107,296	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise deriv	2013-02-08	2013-02-12	41,540	—	$0	184,776	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise deriv	2013-02-08	2013-02-12	38,056	—	$0	146,720	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2013-02-08	2013-02-12	24,232	—	$0	116,086	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise deriv	2013-02-08	2013-02-12	25,013	—	$0	107,040	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise deriv	2013-02-08	2013-02-12	28,140	—	$0	98,808	SEC↗
FANNING STEPHEN J	Chairman President & CEO	M Exercise deriv	2013-02-08	2013-02-12	92,795	—	$0	442,463	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise	2013-02-08	2013-02-12	26,800	—	$0	171,006	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2013-02-08	2013-02-12	10,946	$2.56	$28.0K	160,120	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2013-02-08	2013-02-12	8,776	$2.56	$22.5K	151,344	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise	2013-02-08	2013-02-12	41,540	—	$0	346,652	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2013-02-08	2013-02-12	15,564	$2.56	$39.8K	331,088	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2013-02-08	2013-02-12	13,603	$2.56	$34.8K	317,485	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2013-02-08	2013-02-12	10,103	$2.56	$25.9K	261,621	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2013-02-08	2013-02-12	24,232	—	$0	271,724	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2013-02-08	2013-02-12	7,936	$2.56	$20.3K	253,685	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise	2013-02-08	2013-02-12	25,013	—	$0	199,504	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2013-02-08	2013-02-12	8,192	$2.56	$21.0K	180,794	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2013-02-08	2013-02-12	10,518	$2.56	$26.9K	188,986	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise	2013-02-08	2013-02-12	28,140	—	$0	176,140	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2013-02-08	2013-02-12	11,387	$2.56	$29.2K	164,753	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2013-02-08	2013-02-12	9,215	$2.56	$23.6K	155,538	SEC↗
FANNING STEPHEN J	Chairman President & CEO	M Exercise	2013-02-08	2013-02-12	92,795	—	$0	805,630	SEC↗
FANNING STEPHEN J	Chairman President & CEO	F Tax w/h	2013-02-08	2013-02-12	27,381	$2.56	$70.1K	744,211	SEC↗
FANNING STEPHEN J	Chairman President & CEO	F Tax w/h	2013-02-08	2013-02-12	34,038	$2.56	$87.1K	771,592	SEC↗
FANNING STEPHEN J	Chairman, President & CEO	A Award deriv	2013-02-04	2013-02-06	182,900	—	$0	535,258	SEC↗
Ferrari H Daniel	Vice President of Finance	A Award deriv	2013-02-04	2013-02-06	40,000	—	$0	132,053	SEC↗
GLENN JOHN	Chief Financial Officer	A Award deriv	2013-02-04	2013-02-06	76,800	—	$0	226,316	SEC↗
Heigel Douglas W	VP Operations	A Award deriv	2013-02-04	2013-02-06	46,400	—	$0	140,318	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	A Award deriv	2013-02-04	2013-02-06	40,000	—	$0	134,096	SEC↗
Yorkey Thomas J.	Vice President, Research & D	A Award deriv	2013-02-04	2013-02-06	46,700	—	$0	126,948	SEC↗
FANNING STEPHEN J	Chairman, President & CEO	A Award	2013-02-04	2013-02-06	219,000	—	$0	712,835	SEC↗
Ferrari H Daniel	Vice President of Finance	A Award	2013-02-04	2013-02-06	50,000	—	$0	189,403	SEC↗
GLENN JOHN	Chief Financial Officer	A Award	2013-02-04	2013-02-06	92,000	—	$0	305,112	SEC↗
Heigel Douglas W	VP Operations	A Award	2013-02-04	2013-02-06	56,700	—	$0	247,492	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	A Award	2013-02-04	2013-02-06	50,000	—	$0	144,266	SEC↗
Yorkey Thomas J.	Vice President, Research & D	A Award	2013-02-04	2013-02-06	57,500	—	$0	148,000	SEC↗
Knowlton Edward W	Director	M Exercise deriv	2013-01-16	2013-01-17	10,000	—	$0	0	SEC↗
Knowlton Edward W	Director	M Exercise	2013-01-16	2013-01-17	10,000	$0.45	$4.5K	912,975	SEC↗
Parr Lisa D	VP,Regulatory/Clinical Affai	A Award deriv	2012-12-11	2012-12-13	100,000	—	$0	100,000	SEC↗
Knowlton Edward W	Director	M Exercise deriv	2012-09-14	2012-09-14	10,000	—	$0	0	SEC↗
Knowlton Edward W	Director	M Exercise	2012-09-14	2012-09-14	10,000	$0.45	$4.5K	902,975	SEC↗
Graebner Linda	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	22,909	SEC↗
STANG ERIC B	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	22,909	SEC↗
SIECZKAREK MARK M	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	42,975	SEC↗
McCarthy Cathy L	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	67,975	SEC↗
Knowlton Edward W	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	892,975	SEC↗
COVERT HAROLD L	Director	A Award	2012-06-07	2012-06-11	22,909	—	$0	42,975	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	S Sale	2012-02-21	2012-02-22	20,984	$3.11	$65.3K	94,266	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise deriv	2012-02-17	2012-02-21	18,881	—	$0	52,085	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	S Sale	2012-02-17	2012-02-21	18,881	$3.00	$56.6K	115,250	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise	2012-02-17	2012-02-21	18,881	$1.91	$36.1K	134,131	SEC↗
Ferrari H Daniel	Vice President of Finance	S Sale	2012-02-17	2012-02-22	10,000	$3.13	$31.3K	124,491	SEC↗
Ferrari H Daniel	Vice President of Finance	S Sale	2012-02-17	2012-02-22	4,912	$3.13	$15.4K	134,491	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise deriv	2012-02-16	2012-02-21	4,036	—	$0	70,966	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise	2012-02-16	2012-02-21	4,036	$1.91	$7.7K	119,286	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	S Sale	2012-02-16	2012-02-21	4,036	$3.00	$12.1K	115,250	SEC↗
McCarthy Cathy L	Director	M Exercise deriv	2012-02-15	2012-02-17	25,000	—	$0	0	SEC↗
McCarthy Cathy L	Director	M Exercise	2012-02-15	2012-02-17	25,000	$1.39	$34.8K	45,066	SEC↗
FANNING STEPHEN J	President & CEO	F Tax w/h	2012-02-10	2012-02-13	26,656	$2.99	$79.7K	447,364	SEC↗
Brodie William	Vice President of Global Sal	F Tax w/h	2012-02-10	2012-02-13	8,806	$2.99	$26.3K	145,064	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2012-02-10	2012-02-13	7,314	$2.99	$21.9K	178,774	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2012-02-10	2012-02-13	6,667	$2.99	$19.9K	128,680	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2012-02-10	2012-02-13	6,287	$2.99	$18.8K	105,113	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	F Tax w/h	2012-02-10	2012-02-13	6,117	$2.99	$18.3K	98,883	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2012-02-10	2012-02-13	3,585	$2.99	$10.7K	85,415	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2012-02-10	2012-02-13	10,418	$2.99	$31.1K	191,018	SEC↗
FANNING STEPHEN J	President & CEO	M Exercise deriv	2012-02-09	2012-02-13	73,392	—	$0	352,358	SEC↗
Brodie William	Vice President of Global Sal	M Exercise deriv	2012-02-09	2012-02-13	24,240	—	$0	121,010	SEC↗
Heigel Douglas W	VP Operations	M Exercise deriv	2012-02-09	2012-02-13	20,132	—	$0	93,918	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise deriv	2012-02-09	2012-02-13	18,347	—	$0	92,053	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise deriv	2012-02-09	2012-02-13	17,304	—	$0	94,096	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	M Exercise deriv	2012-02-09	2012-02-13	16,832	—	$0	88,168	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise deriv	2012-02-09	2012-02-13	8,752	—	$0	80,248	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise deriv	2012-02-09	2012-02-13	28,684	—	$0	149,516	SEC↗
FANNING STEPHEN J	President & CEO	F Tax w/h	2012-02-09	2012-02-13	26,921	$2.99	$80.5K	493,835	SEC↗
FANNING STEPHEN J	President & CEO	M Exercise	2012-02-09	2012-02-13	73,392	—	$0	520,756	SEC↗
Brodie William	Vice President of Global Sal	M Exercise	2012-02-09	2012-02-13	24,240	—	$0	169,304	SEC↗
Brodie William	Vice President of Global Sal	F Tax w/h	2012-02-09	2012-02-13	9,555	$2.99	$28.6K	159,749	SEC↗
Heigel Douglas W	VP Operations	F Tax w/h	2012-02-09	2012-02-13	8,114	$2.99	$24.3K	190,792	SEC↗
Heigel Douglas W	VP Operations	M Exercise	2012-02-09	2012-02-13	20,132	—	$0	198,906	SEC↗
Ferrari H Daniel	Vice President of Finance	F Tax w/h	2012-02-09	2012-02-13	7,624	$2.99	$22.8K	139,403	SEC↗
Ferrari H Daniel	Vice President of Finance	M Exercise	2012-02-09	2012-02-13	18,347	—	$0	147,027	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	F Tax w/h	2012-02-09	2012-02-13	7,167	$2.99	$21.4K	115,250	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	M Exercise	2012-02-09	2012-02-13	17,304	—	$0	122,417	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	F Tax w/h	2012-02-09	2012-02-13	7,004	$2.99	$20.9K	108,711	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	M Exercise	2012-02-09	2012-02-13	16,832	—	$0	115,715	SEC↗
Yorkey Thomas J.	Vice President, Research & D	M Exercise	2012-02-09	2012-02-13	8,752	—	$0	94,167	SEC↗
Yorkey Thomas J.	Vice President, Research & D	F Tax w/h	2012-02-09	2012-02-13	3,667	$2.99	$11.0K	90,500	SEC↗
GLENN JOHN	Chief Financial Officer	F Tax w/h	2012-02-09	2012-02-13	10,985	$2.99	$32.8K	208,717	SEC↗
GLENN JOHN	Chief Financial Officer	M Exercise	2012-02-09	2012-02-13	28,684	—	$0	219,702	SEC↗
FANNING STEPHEN J	Chairman, President & CEO	A Award deriv	2012-02-08	2012-02-10	207,750	—	$0	425,750	SEC↗
GLENN JOHN	Chief Financial Officer	A Award deriv	2012-02-08	2012-02-10	93,000	—	$0	178,200	SEC↗
Brodie William	Vice President of Global Sal	A Award deriv	2012-02-08	2012-02-10	73,250	—	$0	145,250	SEC↗
Heigel Douglas W	VP Operations	A Award deriv	2012-02-08	2012-02-10	54,250	—	$0	114,050	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	A Award deriv	2012-02-08	2012-02-10	60,000	—	$0	111,400	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	A Award deriv	2012-02-08	2012-02-10	55,000	—	$0	105,000	SEC↗
Ferrari H Daniel	Vice President of Finance	A Award deriv	2012-02-08	2012-02-10	56,000	—	$0	110,400	SEC↗
Yorkey Thomas J.	Vice President, Research & D	A Award deriv	2012-02-08	2012-02-10	63,000	—	$0	89,000	SEC↗
FANNING STEPHEN J	Chairman, President & CEO	A Award	2012-02-08	2012-02-10	207,750	—	$0	474,020	SEC↗
GLENN JOHN	Chief Financial Officer	A Award	2012-02-08	2012-02-10	93,000	—	$0	201,436	SEC↗
Brodie William	Vice President of Global Sal	A Award	2012-02-08	2012-02-10	73,250	—	$0	153,870	SEC↗
Heigel Douglas W	VP Operations	A Award	2012-02-08	2012-02-10	54,250	—	$0	186,088	SEC↗
Nardoci Jeffrey C	Vice President of Marketing	A Award	2012-02-08	2012-02-10	60,000	—	$0	111,400	SEC↗
Foss Kristine A	VP,Regulatory,Clinical,Quali	A Award	2012-02-08	2012-02-10	55,000	—	$0	105,000	SEC↗
Ferrari H Daniel	Vice President of Finance	A Award	2012-02-08	2012-02-10	56,000	—	$0	135,347	SEC↗
Yorkey Thomas J.	Vice President, Research & D	A Award	2012-02-08	2012-02-10	63,000	—	$0	89,000	SEC↗